Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Articles

Tablet Press with Fastest-in-Class Changeover

Discovery of split and broken tablets led to drug recalls.

FDA Reports Recalls Due to Broken Tablets

Moody's Investor Service reports AbbVie, Amgen, and Roche are the most exposed to biosimilar competition.

Report: Branded Biopharms Most Exposed to Biosimilar Competition

EMA releases an update on its flu vaccine guidance.

European Medicines Agency Updates Seasonal Flu Vaccine Guidance

Mylan Pharmaceuticals launches Hertraz, the world's first trastuzumab biosimilar in India.

Mylan Launches First Trastuzumab Biosimilar in India

BioOutsource will open a new Biosimilar Center of Excellence in Scotland.

BioOutsource To Open New Biosimilar Center of Excellence

PDA works with FDA to create pharmaceutical quality metrics.

Large Industry Cross-Section Contributes to PDA Quality Metrics Recommendations

Eric Langer has over 25 years experience in biotechnology and life sciences strategic marketing management, market research, and publishing. He has held senior management and marketing positions at biopharmaceutical supply companies. He has published and authored many books and reports on topics in Biotechnology, Large-scale BioManufacturing, and bioscience commercialization and communication. He teaches at Johns Hopkins University marketing management, biotech marketing, services marketing, and marketing in a regulated environment. In 1989 he co-founded BioPlan Associates, Inc. to provide market analysis, and strategy to biotech and healthcare organizations.

CMOs may find opportunities in alternative expression services.

Novel Expression Systems Opening CMO Opportunities

Adeline Siew is editor for Pharmaceutical Technology Europe. She is also science editor for Pharmaceutical Technology.

Experts discuss factors affecting drug delivery to the lungs and key considerations when developing inhalation formulations.

Pulmonary Drug Delivery—Particle Engineering for Inhaled Therapeutics

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Automated sample handling, advanced glycan analysis, and specially designed columns are help speed up confirmation of the biosimilarity.